Literature DB >> 19891570

Early experience with high-dosage daptomycin for prosthetic infections.

Francesco G De Rosa, Oscar Mollaretti, Cristina Cometto, Nicole Pagani, Chiara Montrucchio, Giovanni Di Perri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19891570     DOI： 10.1086/648115

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

Review 1.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

2.  Multicenter study of high-dose daptomycin for treatment of enterococcal infections.

Authors:  Anthony M Casapao; Ravina Kullar; Susan L Davis; Donald P Levine; Jing J Zhao; Brian A Potoski; Debra A Goff; Christopher W Crank; John Segreti; George Sakoulas; Sara E Cosgrove; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

3.  High-dose daptomycin therapy for staphylococcal endocarditis and when to apply it.

Authors:  Jordan R Smith; Kimberly C Claeys; Katie E Barber; Michael J Rybak
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

Review 4.  Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections.

Authors:  Armando Gonzalez-Ruiz; R Andrew Seaton; Kamal Hamed
Journal:  Infect Drug Resist       Date:  2016-04-15       Impact factor: 4.003

5.  Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience.

Authors:  R Andrew Seaton; Francesco Menichetti; Georgios Dalekos; Andres Beiras-Fernandez; Francisco Nacinovich; Rashidkhan Pathan; Kamal Hamed
Journal:  Adv Ther       Date:  2015-11-26       Impact factor: 3.845
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.